Complex relationship between Parkin mutations and Parkinson disease.
about
Parkin mono-ubiquitinates Bcl-2 and regulates autophagyDopamine covalently modifies and functionally inactivates parkinGenetics of Parkinson diseaseParkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonismLinking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD)FlyBase portals to human disease research using Drosophila modelsParkin-deficient mice are not a robust model of parkinsonism.Loss of locus coeruleus neurons and reduced startle in parkin null mice.The effects of oxidative stress on parkin and other E3 ligases.Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonismBacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method.Alternative splicing generates different parkin protein isoforms: evidences in human, rat, and mouse brain.How much phenotypic variation can be attributed to parkin genotype?Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.Hypothesis: somatic mosaicism and Parkinson diseaseLack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's diseaseParkin mediates the degradation-independent ubiquitination of Hsp70Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.PINK1 mutation heterozygosity and the risk of Parkinson's disease.RNA knockdown as a potential therapeutic strategy in Parkinson's disease.Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.Identifying the genetic components underlying the pathophysiology of movement disorders.Genetics of Parkinson disease.Progress in the pathogenesis and genetics of Parkinson's disease.A multidisciplinary study of patients with early-onset PD with and without parkin mutations.Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutationsMitochondrial contribution to Parkinson's disease pathogenesis.Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.Twenty years since the discovery of the parkin gene.Relative sensitivity of parkin and other cysteine-containing enzymes to stress-induced solubility alterations.Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease-linked point mutations.Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity.Inactivation of parkin by oxidative stress and C-terminal truncations: a protective role of molecular chaperones.The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.MDPD: an integrated genetic information resource for Parkinson's disease.Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.Parkin gene alterations in ovarian carcinoma from northern Indian population.
P2860
Q24301563-F47B89D3-49E8-4EF7-B355-0EC0907F007FQ24338423-681FD293-AF3B-448D-96E2-D2BF2C0D761DQ24558967-1334C75C-08B8-44A8-BF5B-112756ED0373Q24797173-145DF1EB-089E-46AC-B5D2-FDFC1F928695Q26752685-71759BD2-A909-431B-B288-B4246643A155Q26765019-C3B54EF1-5D53-41EB-9781-6BF9D2E4B0B1Q28504677-782894E1-0B61-4844-8405-5D56D788DBB7Q28593443-304009B6-777E-48F8-9834-368AEEDFAEB3Q30273796-21E90C3F-EF73-4293-8751-34F4B9C1E544Q33275606-E94ECE0C-F97A-4EBF-942D-32D2CC2D0ADFQ33393439-F8CAF91D-66B0-4A9C-95FD-221114FA819EQ33577056-AD84A3D5-DAC8-4995-8175-51FC87B6098CQ33721033-BFE6D817-D674-4710-A181-19DEB23AC4F2Q34014415-48AEFBB7-F447-4961-ADA3-E2AD67F0579BQ34218728-B2C28145-6526-4671-8173-1BC681B379E3Q34528753-B2145725-2DFD-49ED-80C0-CB2FC6BD8D88Q34774314-E7A5FAE2-D7B5-4D0E-BB05-E70332C06062Q35237757-171E88DE-6E53-44A2-A6F3-CCEA222F5580Q35609973-2A296DFD-335E-455C-8D57-55C5BC14C603Q35898027-F1D9432F-6139-44A7-B710-C1857E510109Q36227281-4F7AE21C-8D72-4FDB-BF88-303168781C95Q36305419-BA2E7E94-5125-4D8D-AA78-866310581774Q36499640-25BA6F89-3E04-4992-8378-D10F9D656A10Q36761674-7CC21EAA-56E2-4C44-B27F-D98FB6B17B86Q36925207-3651CD1F-0311-4239-9A63-02DEDF42E67AQ37037053-8CBED2C6-B769-4611-BDFF-3E19814AAC0DQ37143657-102F582A-5368-4575-BCD2-852C06734D7AQ37180446-6877D934-B577-4563-904A-0D844F46A658Q37273558-7D17C159-72E4-495C-9354-E163D86399A3Q37891820-7DE7B909-8D72-472D-B009-FFA0E97B9FF4Q39230378-F243B28A-F195-4658-96F4-C8299A6CC759Q39377582-382C7D64-FDA5-4AA6-BAC6-256671940E55Q40165324-53D53AFF-86E7-4DB5-B8B3-F42BDC44FC1EQ40437542-AE7A6926-4DFF-4169-AC01-5AC56882FB45Q40489168-1FC57F5D-AA9B-45B9-9AED-D12DD6C27C03Q40634794-F0D08650-7D0B-4298-B229-68E9ED0B8FF4Q42116736-7993F322-51CE-401D-B14B-B2290E0B5BD5Q43122461-0E046A47-D12C-47FD-B120-398B343AA354Q43123357-8216C7FE-A5BE-4D9D-A2DC-95410E2BF55DQ44281189-37EE5B12-8E57-42FD-A622-86DCF259C166
P2860
Complex relationship between Parkin mutations and Parkinson disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Complex relationship between Parkin mutations and Parkinson disease.
@ast
Complex relationship between Parkin mutations and Parkinson disease.
@en
Complex relationship between Parkin mutations and Parkinson disease.
@nl
type
label
Complex relationship between Parkin mutations and Parkinson disease.
@ast
Complex relationship between Parkin mutations and Parkinson disease.
@en
Complex relationship between Parkin mutations and Parkinson disease.
@nl
prefLabel
Complex relationship between Parkin mutations and Parkinson disease.
@ast
Complex relationship between Parkin mutations and Parkinson disease.
@en
Complex relationship between Parkin mutations and Parkinson disease.
@nl
P2093
P50
P356
P1476
Complex relationship between Parkin mutations and Parkinson disease.
@en
P2093
Allan Levey
Andrew West
Christoph B Lücking
David Nicholl
Demetrius Maraganore
Ebba Lohmann
French Parkinson's Disease Gen ...... ibility on Parkinson's Disease
Jean-François Deleuze
Magali Periquet
Matt Farrer
P304
P356
10.1002/AJMG.10525
P577
2002-07-01T00:00:00Z